CSPC Pharmaceutical Group Statistics
Total Valuation
FRA:CVG has a market cap or net worth of EUR 10.03 billion. The enterprise value is 9.18 billion.
Market Cap | 10.03B |
Enterprise Value | 9.18B |
Important Dates
The last earnings date was Friday, May 23, 2025.
Earnings Date | May 23, 2025 |
Ex-Dividend Date | Oct 31, 2024 |
Share Statistics
Current Share Class | 11.43B |
Shares Outstanding | n/a |
Shares Change (YoY) | -1.85% |
Shares Change (QoQ) | -1.02% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 7.82B |
Valuation Ratios
The trailing PE ratio is 18.75 and the forward PE ratio is 15.90.
PE Ratio | 18.75 |
Forward PE | 15.90 |
PS Ratio | 2.91 |
PB Ratio | 2.32 |
P/TBV Ratio | 2.66 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 17.17 |
EV / Sales | 2.83 |
EV / EBITDA | 12.56 |
EV / EBIT | 15.94 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.08 |
Debt / FCF | n/a |
Interest Coverage | 109.38 |
Financial Efficiency
Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 8.64%.
Return on Equity (ROE) | 12.21% |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 8.64% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 161,109 |
Profits Per Employee | 24,982 |
Employee Count | 21,400 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -6.62% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -6.62% |
50-Day Moving Average | 0.66 |
200-Day Moving Average | 0.62 |
Relative Strength Index (RSI) | 72.23 |
Average Volume (20 Days) | 2,912 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:CVG had revenue of EUR 3.45 billion and earned 534.62 million in profits. Earnings per share was 0.05.
Revenue | 3.45B |
Gross Profit | 2.36B |
Operating Income | 617.93M |
Pretax Income | 677.85M |
Net Income | 534.62M |
EBITDA | 761.58M |
EBIT | 617.93M |
Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.17 billion in cash and 64.68 million in debt, giving a net cash position of 1.10 billion.
Cash & Cash Equivalents | 1.17B |
Total Debt | 64.68M |
Net Cash | 1.10B |
Net Cash Per Share | n/a |
Equity (Book Value) | 4.32B |
Book Value Per Share | 0.36 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 68.45%, with operating and profit margins of 17.92% and 15.51%.
Gross Margin | 68.45% |
Operating Margin | 17.92% |
Pretax Margin | 19.66% |
Profit Margin | 15.51% |
EBITDA Margin | 22.09% |
EBIT Margin | 17.92% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 4.88%.
Dividend Per Share | 0.04 |
Dividend Yield | 4.88% |
Dividend Growth (YoY) | 19.27% |
Years of Dividend Growth | 3 |
Payout Ratio | n/a |
Buyback Yield | 1.85% |
Shareholder Yield | 6.72% |
Earnings Yield | 5.33% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on October 15, 2020. It was a forward split with a ratio of 1.6.
Last Split Date | Oct 15, 2020 |
Split Type | Forward |
Split Ratio | 1.6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |